COMPARISON OF EFFICACY OF DIFFERENT HYPOTENSIVE MEDICINES IN PRIMARY AND SECONDARY PREVENTION OF VASCULAR DISEASES OF BRAIN AND HEART

Download full text PDF
Issue: 
8
Year: 
2015

Professor V. Kovalchuck, MD N.A. Semashko Sity Hospital №38, Saint Petersburg

The aim of present investigation is research of efficacy of different hypotensive medicines in primary and secondary prevention of vascular diseases of brain and heart.
Keywords: 
arterial hypertension
stroke
primary prevention
secondary prevention
Monopril

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gusev E.I., Skvortsova V.I., Stahovskaja L.V. Problema insul'ta v Rossijskoj Federatsii: vremja aktivnyh sovmestnyh dejstvij // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2007; 8: 4–10.
  2. Ivanova G.E., Shklovskij V.M., Petrova E.A. i dr. Printsipy organizatsii rannej reabilitatsii bol'nyh s insul'tom // Kachestvo zhizni. Meditsina. – 2006; 2 (13): 62–70.
  3. Karakulova Ju.V., Amirahova L.Sh. Nejropsihologicheskij status i kachestvo zhizni patsientov v vosstanovitel'nom periode ishemicheskogo insul'ta pod vlijaniem nejroprotektornoj terapii // Ural'skij meditsin-skij zhurnal. – 2013; 1: 21–4.
  4. Kravtsova E.Ju., Martynova G.A., Kravtsova T.Ju. Klinicheskie osobenno sti raznyh podtipov ishemicheskogo insul'ta u lits trudosposobnogo vozrasta // Permskij meditsinskij zhurnal. – 2011; 4: 17–21
  5. Skvortsova V.I., Evzel'man M.A. Ishemicheskij insul't / Orel, 2006; 404 5. s.
  6. Arabidze G.G., Belousov Ju.B., Karpov Ju.A. Arterial'naja gipertonija. Spravochnoe rukovodstvo po diagnostike i lecheniju / M., 1999; 139 s.
  7. Gusev E.I., Martynov M.Ju., Jasamanova A.N. i dr. Etiologicheskie faktory i faktory riska hronicheskoj sosudistoj mozgovoj nedostatochnosti i ishemicheskogo insul'ta // Insul't. – 2001; 1: 41–5.
  8. Parfenov V.A., Verbitskaja S.V. Profilaktika insul'ta na osnove snizhenija arterial'nogo davlenija i issledovanie POWER // Nevrologija. Nejropsihiatrija. Psihosomatika. – 2013; 1: 64–8.
  9. Collins R., MacMachon S. Blood pressure, antihyperetensive drug treatment and the risk of stroke and of coronary heart disease // Br. Med. Bull. – 1994; 50: 272–98.
  10. Keli S., Bloemberg B., Kromhout D. Predictive value of repeated systolic blood pressure measurments for stroke risk: the Zutphen Study // Stroke. – 1992; 23: 347–51.
  11. Warlow C., Dennis M., van Gijn J. et al. Stroke. A practical guide to management / London: Blackwell Science, 1997; 664 r.
  12. Almazov V.A., Arabidze G.G., Belousov Ju.B. i dr. Profilaktika, diagnostika i lechenie pervichnoj arterial'noj gipertonii v Rossijskoj Federatsii // Klin. farmakol. i terapija. – 2000; 9 (1): 5–30.
  13. Rumjantseva S.A., Silina E.V. Energokorrektsija i kachestvo zhizni pri hronicheskoj ishemii mozga / M.: Meditsinskaja kniga, 2007; 60 s.
  14. O’Grady B. The development and implementation of a comprehensive model for stroke services // Zhurn. nevrol. i psihiat. im. S.S.Korsakova. Insul't (pril.). – 2007; Spetsvyp.: 136–8.
  15. Camm A., Kirchhof P., Gregory Y. et al. Guidelines for the management of atrial fibrillation // Eur. Heart J. – 2010; 31: 2369–429.
  16. Makolkin V.I. Metabolicheskij sindrom / M.: MIA, 2010; 144 s.
  17. Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in Adults // J. Clin. Sleep Med. – 2009; 5: 263–76.
  18. WHO-ISH Hypertension guidelines Committee, 1999. – World Heath Organization – International Society of Hypertension guidelines for the Management of Hypertension // J. Hypertens. – 1999; 17: 151–85.
  19. Conroy R., Pyorala K., Fitzgerald A. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project // Eur. Heart J. – 2003; 24: 987–1003.
  20. World Medical Association. Declaration of Helsinki – ethical principles for medical research involving human subjects (DoH/Oct2008). Retrieved December 7, 2010, from: http://www.wma.net/en/30publications/10policies/b3/index.html
  21. Sidorenko B.A., Savchenko M.V., Preobrazhenskij D.V. Ingibitory angiotenzinprevraschajuschego fermenta pri lechenii gipertonicheskoj bolez-ni // Kardiologija. – 2000; 2: 74–82.
  22. Wagstaff A., Davies R., McTavish D. Fosinopril. A reappraisal of its pharmacology and therapeutic efficacy in essential hypertension // Drugs. – 1996; 51 (5): 777–91.
  23. Preobrazhenskij D.V., Savchenko M.V. Fozinopril – pervyj predstavitel' novogo pokolenija ingibitorov angiotenzinprevraschajuschego fermenta // Kardiologija. – 2000; 5: 75–81.
  24. Karpov Ju.A. Fozinopril pri lechenii arterial'noj gipertonii 24. (FLAG): rossijskaja programma otsenki prakticheskoj dostizhimosti tselevyh urovnej arterial'nogo davlenija // Rus. med. zhurn. – 2001; 10: 406–10.